Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kite Pharma, Inc. | 30,575 | reported | 15 Mar 2016 | tx 87+204,507−235,982 |
| Unity Biotechnology, Inc. | 10,000 | reported | 21 Jun 2024 | tx 7+166,661 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Jun 2024 | GRANT_AWARD | Unity Biotechnology, Inc. | 10,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Unity Biotechnology, Inc. | 6,000 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Unity Biotechnology, Inc. | 25,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | Unity Biotechnology, Inc. | 25,000 | 0.00 USD | deriv |
| 18 Jun 2020 | GRANT_AWARD | Unity Biotechnology, Inc. | 25,000 | 0.00 USD | deriv |
| 20 Jun 2019 | GRANT_AWARD | Unity Biotechnology, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Dec 2018 | GRANT_AWARD | Unity Biotechnology, Inc. | 50,661 | 0.00 USD | deriv |
| 15 Mar 2016 | SALE | Kite Pharma, Inc. | 436 | 46.34 USD | |
| 15 Mar 2016 | SALE | Kite Pharma, Inc. | 255 | 47.78 USD | |
| 15 Mar 2016 | EXERCISE | Kite Pharma, Inc. | 1,006 | 17.00 USD | |
| 15 Mar 2016 | EXERCISE | Kite Pharma, Inc. | 7,500 | 0.70 USD | |
| 15 Mar 2016 | SALE | Kite Pharma, Inc. | 7,815 | 45.09 USD | |
| 15 Mar 2016 | EXERCISE | Kite Pharma, Inc. | 7,500 | 0.00 USD | deriv |
| 15 Mar 2016 | EXERCISE | Kite Pharma, Inc. | 1,006 | 0.00 USD | deriv |
| 17 Feb 2016 | SALE | Kite Pharma, Inc. | 9,532 | 45.05 USD | |
| 17 Feb 2016 | EXERCISE | Kite Pharma, Inc. | 9,632 | 0.70 USD | |
| 17 Feb 2016 | SALE | Kite Pharma, Inc. | 100 | 46.01 USD | |
| 17 Feb 2016 | EXERCISE | Kite Pharma, Inc. | 9,632 | 0.00 USD | deriv |
| 12 Feb 2016 | EXERCISE | Kite Pharma, Inc. | 18,750 | 0.70 USD | |
| 12 Feb 2016 | SALE | Kite Pharma, Inc. | 18,750 | 64.16 USD | |
| 12 Feb 2016 | EXERCISE | Kite Pharma, Inc. | 18,750 | 0.00 USD | deriv |
| 15 Jan 2016 | SALE | Kite Pharma, Inc. | 1,054 | 55.83 USD | |
| 15 Jan 2016 | EXERCISE | Kite Pharma, Inc. | 645 | 17.00 USD | |
| 15 Jan 2016 | SALE | Kite Pharma, Inc. | 200 | 57.73 USD | |
| 15 Jan 2016 | SALE | Kite Pharma, Inc. | 400 | 56.90 USD |